Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma (Q33710169)
scientific article published on October 4, 2010
Language:
(P31) (Q13442814)
(P50) (Q1901570)
(Q90652921)
(Q108656165)
(Q89041975)
(Q114372268)
(Q114372269)
(Q114372270)
(Q114372272)
(P304) 524
(P407) (Q1860)
(P478) 10
(P577) Monday, October 4, 2010
(P921) (Q1164529)
(Q66660300)
(P953) https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-10-524
http://www.biomedcentral.com/1471-2407/10/524
http://www.biomedcentral.com/content/pdf/1471-2407-10-524.pdf
http://www.biomedcentral.com/1471-2407/10/524/abstract
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20920340/pdf/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20920340/?tool=EBI
https://europepmc.org/articles/PMC2958940
https://europepmc.org/articles/PMC2958940?pdf=render
http://link.springer.com/content/pdf/10.1186/1471-2407-10-524.pdf
http://link.springer.com/article/10.1186/1471-2407-10-524/fulltext.html
http://link.springer.com/content/pdf/10.1186/1471-2407-10-524
https://link.springer.com/content/pdf/10.1186/1471-2407-10-524.pdf
(P1433) (Q326300)
(P1476) "Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma" (language: en)
(P2093) Johannes Hüsing
Peter Schirmacher
(P2860) (Q29547625)
(Q37372973)
(Q37131382)
(Q39910321)
(Q36897759)
(Q29618031)
(Q38289292)
(Q37054515)
(Q34586436)
(Q40050697)
(Q34619655)
(Q28282767)
(Q28282757)
(Q36612554)
(Q40233613)
(Q40273857)
(Q24299020)
(Q44864337)
(Q42812559)
(Q36616798)
(Q38704458)
(Q34293726)
(Q34268216)
(Q24672969)
(Q35009888)
(Q29615395)
(Q29614514)
(Q28131795)
(Q46854143)
(Q47314793)
(Q46099462)
(Q56019528)
(Q52979961)
(Q52975859)
(Q46058434)
(Q52907786)
(Q83161784)
(Q81243903)
(Q73471131)
(Q864239)
(Q27714220)
other details
description scientific article published on October 4, 2010

External Links